|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-10-22
|
|
pubmed:abstractText |
Perennial allergic rhinitis impairs social life, but it is not known whether quality of life may be improved when patients are treated with an H1-blocker. A randomized, double-blind, placebo-controlled study was carried out with cetirizine to assess the effect of this drug on quality of life.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0091-6749
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
98
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
309-16
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8757208-Adolescent,
pubmed-meshheading:8757208-Adult,
pubmed-meshheading:8757208-Belgium,
pubmed-meshheading:8757208-Cetirizine,
pubmed-meshheading:8757208-Double-Blind Method,
pubmed-meshheading:8757208-Follow-Up Studies,
pubmed-meshheading:8757208-France,
pubmed-meshheading:8757208-Health Surveys,
pubmed-meshheading:8757208-Humans,
pubmed-meshheading:8757208-Middle Aged,
pubmed-meshheading:8757208-Patient Compliance,
pubmed-meshheading:8757208-Quality of Life,
pubmed-meshheading:8757208-Questionnaires,
pubmed-meshheading:8757208-Rhinitis, Allergic, Perennial,
pubmed-meshheading:8757208-Treatment Outcome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire.
|
|
pubmed:affiliation |
Services des Maladies Respiratoires, Hôpital Arnaud de Villeneuve, Montpellier, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
